In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: GE HealthCare Technologies trades 81% below a high-confidence fair value estimate of $127.41, indicating significant undervaluation supported by multiple valuation methods. Strong profitability (5/5) contrasts with moderate growth (2/5) and financial health (3.2/5), while Monte Carlo analysis shows high volatility but limited downside risk (11.4%). The wide value range and high standard deviation reveal substantial upside potential accompanied by notable investment risk.